Fortesta

DRUG2 trials

Sponsors

Endo Pharmaceuticals, Walter Reed National Military Medical Center

Conditions

Gender Identity DysphoriaHypogonadismHypogonadism, MaleHypogonadotropic Hypogonadism

Phase 4

A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

CompletedNCT04456296

Endo PharmaceuticalsHypogonadism, Hypogonadism, Male, Hypogonadotropic Hypogonadism

Start: 2020-06-30End: 2023-07-12Updated: 2025-03-14

Unknown Phase

The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population

RecruitingNCT06247267

Walter Reed National Military Medical CenterGender Identity Dysphoria, Hypogonadism

Start: 2021-03-09End: 2025-08-31Target: 75Updated: 2025-07-29